CDK9-IN-1
Code | Size | Price |
---|
TAR-T10741-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T10741-50mg | 50mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection (IC50: 39 nM for CDK9/CycT1).
CAS:
1415559-43-1
Formula:
C26H21N5O4S
Molecular Weight:
499.55
Pathway:
Cell Cycle/Checkpoint
Purity:
0.98
SMILES:
Cc1ccc(Nc2cc(ncn2)-c2cccc(c2)N2C(=O)c3ccccc3C2=O)cc1NS(C)(=O)=O
Target:
CDK
References
1. Nemeth G, et al. Novel, selective CDK9 inhibitors for the treatment of HIV infection. Curr Med Chem. 2011;18(3):342-358.